Egfr - epidermal growth factor receptor Gene

Also Known as Wa5; wa2; Erbb; Errp; wa-2; Errb1; 9030024J15Rik

Species: Mus musculus

Gene Type: protein coding
Gene ID: 13649

About Egfr

Chromosome 11: 16,702,203-16,868,158 forward strand.GRCm39:CM001004.3

This gene has 5 transcripts (splice variants), 283 orthologues, 53 paralogues and is associated with 180 phenotypes. Broad expression in liver adult (RPKM 26.7), liver E18 (RPKM 8.7) and 15 other tissues.

Summary

Enables epidermal growth factor binding activity and epidermal growth factor-activated receptor activity. Involved in cellular response to amino acid stimulus and positive regulation of fibroblast proliferation. Acts upstream of or within several processes, including animal organ development; epidermal growth factor receptor signaling pathway; and protein autophosphorylation. Located in several cellular components, including basolateral plasma membrane; endocytic vesicle; and perinuclear region of cytoplasm. Is expressed in several structures, including alimentary system; brain; integumental system; limb; and respiratory system. Used to study Coronavirus infectious disease and aortic valve disease. Human ortholog(s) of this gene implicated in several diseases, including colorectal cancer; lung non-small cell carcinoma (multiple); pancreatic cancer; prostate cancer; and pulmonary tuberculosis. Orthologous to human EGFR (epidermal growth factor receptor). [provided by Alliance of Genome Resources, Apr 2022]

Egfr Products (2)

mRNA Protein Name
NM_207655.2 NP_997538.1 epidermal growth factor receptor isoform 1 precursor
NM_007912.4 NP_031938.1 epidermal growth factor receptor isoform 2 precursor

Gene Ontology

  • Molecular Function
  • Biological Process
  • Cellular Component
Molecular Function GO Annotation Evidence References Source
enables epidermal growth factor binding IDA
IDA: Inferred from direct assay
7678348 MGI
enables epidermal growth factor receptor activity IDA
IDA: Inferred from direct assay
6248866 MGI
enables epidermal growth factor receptor activity IGI
IGI: Inferred from genetic interaction
16357442 MGI
enables epidermal growth factor receptor activity IMP
IMP: Inferred from mutant phenotype
18701712 MGI
enables kinase activity IDA
IDA: Inferred from direct assay
12808090 MGI
enables protein binding IPI
IPI: Inferred from physical interaction
11274221 MGI
enables protein tyrosine kinase activity IDA
IDA: Inferred from direct assay
15383614 MGI
enables protein tyrosine kinase activity IMP
IMP: Inferred from mutant phenotype
11823423 MGI
enables transmembrane receptor protein tyrosine kinase activity IDA
IDA: Inferred from direct assay
7752576 MGI
enables transmembrane receptor protein tyrosine kinase activity IGI
IGI: Inferred from genetic interaction
28783046 MGI
enables transmembrane receptor protein tyrosine kinase activity IMP
IMP: Inferred from mutant phenotype
12399441 MGI
Biological Process GO Annotation Evidence References Source
involved in ERBB2-EGFR signaling pathway IDA
IDA: Inferred from direct assay
8702723 MGI
involved in ERBB2-EGFR signaling pathway IMP
IMP: Inferred from mutant phenotype
18701712 MGI
acts upstream of or within cell morphogenesis IGI
IGI: Inferred from genetic interaction
17686994 MGI
acts upstream of cell population proliferation IGI
IGI: Inferred from genetic interaction
18656477 MGI
involved in cellular response to amino acid stimulus IDA
IDA: Inferred from direct assay
22711986 MGI
acts upstream of or within cellular response to growth factor stimulus IDA
IDA: Inferred from direct assay
8702723 MGI
acts upstream of or within cerebral cortex cell migration IMP
IMP: Inferred from mutant phenotype
7618084 MGI
acts upstream of or within digestive tract morphogenesis IMP
IMP: Inferred from mutant phenotype
7618084 MGI
acts upstream of or within embryonic placenta development IMP
IMP: Inferred from mutant phenotype
7618084 MGI
acts upstream of or within epidermal growth factor receptor signaling pathway IDA
IDA: Inferred from direct assay
14712229 MGI
involved in epidermal growth factor receptor signaling pathway IDA
IDA: Inferred from direct assay
6248866 MGI
acts upstream of or within epidermal growth factor receptor signaling pathway IGI
IGI: Inferred from genetic interaction
7641815 MGI
involved in epidermal growth factor receptor signaling pathway IGI
IGI: Inferred from genetic interaction
28783046 MGI
acts upstream of or within epidermal growth factor receptor signaling pathway IMP
IMP: Inferred from mutant phenotype
17686994 MGI
involved in epidermal growth factor receptor signaling pathway IMP
IMP: Inferred from mutant phenotype
12399441 MGI
acts upstream of or within epidermis development IMP
IMP: Inferred from mutant phenotype
7618084 MGI
acts upstream of epithelial cell proliferation IMP
IMP: Inferred from mutant phenotype
7618084 MGI
acts upstream of or within eyelid development in camera-type eye IGI
IGI: Inferred from genetic interaction
9030684 MGI
acts upstream of or within hair follicle development IGI
IGI: Inferred from genetic interaction
9030684 MGI
acts upstream of or within hair follicle development IMP
IMP: Inferred from mutant phenotype
7618084 MGI
acts upstream of or within morphogenesis of an epithelial fold IMP
IMP: Inferred from mutant phenotype
7618084 MGI
involved in negative regulation of epidermal growth factor receptor signaling pathway IDA
IDA: Inferred from direct assay
23457600 MGI
involved in negative regulation of epidermal growth factor receptor signaling pathway IMP
IMP: Inferred from mutant phenotype
11823423 MGI
acts upstream of or within positive regulation of cell population proliferation IDA
IDA: Inferred from direct assay
14712229 MGI
acts upstream of or within positive regulation of cell population proliferation IGI
IGI: Inferred from genetic interaction
7641815 MGI
acts upstream of or within positive regulation of epithelial cell proliferation IMP
IMP: Inferred from mutant phenotype
7618084 MGI
involved in positive regulation of fibroblast proliferation IMP
IMP: Inferred from mutant phenotype
20208556 MGI
acts upstream of or within protein autophosphorylation IDA
IDA: Inferred from direct assay
15314156 MGI
acts upstream of or within regulation of cell population proliferation IGI
IGI: Inferred from genetic interaction
11818567 MGI
acts upstream of or within regulation of peptidyl-tyrosine phosphorylation IMP
IMP: Inferred from mutant phenotype
11940581 MGI
acts upstream of or within salivary gland morphogenesis IMP
IMP: Inferred from mutant phenotype
10521784 MGI
acts upstream of or within signal transduction IDA
IDA: Inferred from direct assay
11940581 MGI
Cellular Component GO Annotation Evidence References Source
located in basolateral plasma membrane IDA
IDA: Inferred from direct assay
7723235 MGI
located in cell surface IDA
IDA: Inferred from direct assay
23918928 MGI
located in endocytic vesicle IDA
IDA: Inferred from direct assay
10534613 MGI
located in intracellular anatomical structure IDA
IDA: Inferred from direct assay
10534613 MGI
located in nucleus IDA
IDA: Inferred from direct assay
20208556 MGI
located in perinuclear region of cytoplasm IDA
IDA: Inferred from direct assay
20208556 MGI
is active in plasma membrane IDA
IDA: Inferred from direct assay
6248866 MGI
located in plasma membrane IDA
IDA: Inferred from direct assay
7641815 MGI
is active in plasma membrane IGI
IGI: Inferred from genetic interaction
28783046 MGI
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

Egfr Protein Structure

Recep_L_domain

Recep_L_domain: pfam01030 (56 - 167)

Furin-like

Furin-like: pfam00757 (183 - 334)

Recep_L_domain

Recep_L_domain: pfam01030 (361 - 480)

GF_recep_IV

GF_recep_IV: pfam14843 (504 - 635)

TM_ErbB1

TM_ErbB1: cd12093 (633 - 678)

PTKc_EGFR

PTKc_EGFR: cd05108 (705 - 1017)

  • 0
  • 200
  • 400
  • 600
  • 800
  • 1000
  • 1210 a.a.
Protein Preferred Names Protein Names

epidermal growth factor receptor

  • avian erythroblastic leukemia viral (v-erb-b) oncogene homolog

  • waved 2

Recombinant Egfr Proteins

Cat. No. Product Name Accession Purity
HY-P72988 EGFR Protein, Mouse (HEK293, Fc) Q01279 (L25-S647) ≥ 95%, as determined by reducing SDS-PAGE.
HY-P72989 EGFR Protein, Mouse (HEK293, His, solution) Q01279 (L25-S647) ≥ 95%, as determined by reducing SDS-PAGE.

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (49)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-15772 Osimertinib Inhibitor 99.96% Yes
HY-50895 Gefitinib Inhibitor 99.99% Yes
HY-138298A Trastuzumab deruxtecan Inhibitor 99.68% Unkown
HY-50896 Erlotinib Inhibitor 99.99% Yes
HY-10261 Afatinib Inhibitor 99.92% Yes
HY-138298 Trastuzumab deruxtecan (solution) Inhibitor 99.40% Unkown
HY-50898 Lapatinib Inhibitor 99.83% Yes
HY-16069 Tucatinib Inhibitor 99.82% Yes
HY-P9921 Trastuzumab emtansine Inhibitor 99.74% Unkown
HY-32721 Neratinib Inhibitor 99.94% Yes
HY-P9985 Disitamab vedotin Inhibitor 99.06% Unkown
HY-13272 Dacomitinib Inhibitor 99.74% Yes
HY-15772A Osimertinib mesylate Inhibitor 99.97% Yes
HY-109061 Lazertinib Inhibitor 99.87% Unkown
HY-P9921A Trastuzumab emtansine (solution) 98.27% Unkown
HY-12008 Erlotinib Hydrochloride Inhibitor 99.94% Yes
HY-10261A Afatinib dimaleate Inhibitor 99.74% Yes
HY-112870 Firmonertinib Inhibitor 99.89% Unkown
HY-112823 Almonertinib Inhibitor 99.83% Unkown
HY-50895A Gefitinib hydrochloride Inhibitor 99.85% Yes
HY-104065 Pyrotinib Inhibitor 99.89% Unkown
HY-132842 Sunvozertinib Inhibitor 99.62% Unkown
HY-N0281 Daphnetin Inhibitor 99.77% Unkown
HY-135815 Mobocertinib Inhibitor 99.60% Yes
HY-15164A Icotinib Inhibitor 99.96% Yes
HY-79077 Osimertinib dimesylate Inhibitor 99.96% Yes
HY-32721B Neratinib maleate Inhibitor 99.74% Yes
HY-164718 Sevabertinib Inhibitor 99.90% Unkown
HY-50898A Lapatinib ditosylate Inhibitor 99.98% Yes
HY-19730 Olmutinib Inhibitor 99.88% Unkown
HY-112870A Firmonertinib mesylate Inhibitor 99.97% Unkown
HY-15772R Osimertinib (Standard) Inhibitor 99.69% Unkown
HY-50898B Lapatinib ditosylate monohydrate Inhibitor 99.99% Yes
HY-104065B Pyrotinib dimaleate Inhibitor 98.04% Unkown
HY-112823A Almonertinib mesylate Inhibitor 99.67% Unkown
HY-112823B Almonertinib hydrochloride Inhibitor 98.92% Unkown
HY-135815A Mobocertinib succinate Inhibitor 99.83% Yes
HY-50896R Erlotinib (Standard) Inhibitor 99.97% Unkown
HY-16069A Tucatinib hemiethanolate Inhibitor 98.82% Yes
HY-15164 Icotinib Hydrochloride Inhibitor 99.89% Yes
HY-50895R Gefitinib (Standard) Inhibitor 99.94% Unkown
HY-118263 Dacomitinib hydrate Inhibitor 99.54% Unkown
HY-12008R Erlotinib Hydrochloride (Standard) Inhibitor 99.73% Unkown
HY-50898C Lapatinib tosylate Inhibitor / Unkown
HY-50895B Gefitinib dihydrochloride Inhibitor / Unkown
HY-135815B Mobocertinib mesylate Inhibitor / Unkown
HY-10261D Afatinib oxalate Inhibitor / Unkown
HY-101820A Simotinib hydrochloride Inhibitor / Unkown
HY-12008A Erlotinib mesylate Inhibitor / Unkown
Inhibitory Antibodies (10)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-P9907 Trastuzumab Inhibitor 99.80% Unkown
HY-P9905 Cetuximab Inhibitor 99.81% Unkown
HY-P9977 Amivantamab Inhibitor 99.90% Unkown
HY-P9912 Pertuzumab Inhibitor 99.80% Unkown
HY-P99041 Panitumumab Inhibitor 99.77% Unkown
HY-P99380 Zanidatamab Inhibitor 98.56% Unkown
HY-P99507 Zenocutuzumab Inhibitor 99.9% Unkown
HY-P9968 Nimotuzumab Inhibitor 96.80% Unkown
HY-P9964 Necitumumab Inhibitor 99.90% Unkown
HY-P99030 Margetuximab Inhibitor ≥99.0% Unkown

Clinical Phase

Bioactive Molecules (78)
Cat. No. Product Name Effect
Purity Phase
HY-14596 Genistein Inhibitor 99.82% Phase 4
HY-137433 Befotertinib Inhibitor 99.86% Phase 4
HY-131686 Ganglioside GT1b (bovine) ammonium Activator 98.0% Phase 4
HY-50895G Gefitinib (GMP) Inhibitor / Phase 4
HY-164702 BL-B01D1 Inhibitor 99.65% Phase 3
HY-18750 Zorifertinib Inhibitor 99.37% Phase 3
HY-171265 Becotatug vedotin Degrader 96.99% Phase 3
HY-15729 Rociletinib Inhibitor 99.67% Phase 3
HY-15730 Poziotinib Inhibitor 99.96% Phase 3
HY-132259 Depatuxizumab mafodotin 99.65% Phase 3
HY-12872 Nazartinib Inhibitor 99.53% Phase 3
HY-164762 Trastuzumab rezetecan Inhibitor 98.01% Phase 3
HY-112299 Zipalertinib Inhibitor 99.62% Phase 3
HY-139920 Oritinib Inhibitor 99.59% Phase 3
HY-19803 Naquotinib mesylate Inhibitor 98.06% Phase 3
HY-19816A Avitinib maleate Inhibitor 99.86% Phase 3
HY-13314 Tesevatinib Inhibitor 99.41% Phase 3
HY-120590 Ruserontinib Inhibitor 99.32% Phase 3
HY-138751A limertinib diTFA Inhibitor 98.96% Phase 3
HY-118998 TX2-121-1 Inhibitor / Phase 3
HY-10530A Varlitinib tosylate Inhibitor / Phase 3
HY-106204 Nelipepimut-S / Phase 3
HY-109189A Rezivertinib hydrochloride Inhibitor / Phase 3
HY-N14349 Asterriquinone Inhibitor / Phase 3
HY-172820 Trastuzumab envedotin Inhibitor / Phase 3
HY-13050 Sapitinib Inhibitor 99.93% Phase 2
HY-10367 Canertinib Inhibitor 99.74% Phase 2
HY-32718 Pelitinib Inhibitor 99.13% Phase 2
HY-153268 Silevertinib Inhibitor 99.74% Phase 2
HY-10045 AEE788 Inhibitor 98.39% Phase 2
HY-14674 CP-724714 Inhibitor 98.72% Phase 2
HY-10333 BMS-690514 Inhibitor 99.68% Phase 2
HY-19985 PF-06459988 Inhibitor 99.10% Phase 2
HY-12972 Mavelertinib Inhibitor 99.34% Phase 2
HY-17632 Tarloxotinib bromide Inhibitor 98.75% Phase 2
HY-172429A Enozertinib hemihydrate Inhibitor 99.98% Phase 2
HY-19815 Olafertinib Inhibitor 99.51% Phase 2
HY-10251 BMS-599626 Inhibitor 98.56% Phase 2
HY-107367A Epertinib hydrochloride Inhibitor 98.15% Phase 2
HY-19909 NRC-2694 Antagonist 99.84% Phase 2
HY-155537 Pruvonertinib Inhibitor 99.50% Phase 2
HY-143319 SPH5030 Inhibitor 99.40% Phase 2
HY-W423595 BEBT-109 Inhibitor 98.72% Phase 2
HY-153974 BBT-176 Inhibitor 98.98% Phase 2
HY-107367 Epertinib Inhibitor ≥98.0% Phase 2
HY-177414 BB-1701 Inhibitor 98.81% Phase 2
HY-101756 SDZ281-977 98.00% Phase 2
HY-164387A Sutetinib maleate Inhibitor / Phase 2
HY-10223 CUDC-101 Inhibitor 99.05% Phase 1
HY-13501 Mubritinib Inhibitor 99.91% Phase 1
HY-18957 Lifirafenib Inhibitor 98.01% Phase 1
HY-144680 BLU-945 Inhibitor 99.61% Phase 1
HY-14346 PD153035 Inhibitor 98.56% Phase 1
HY-171124 Tilatamig samrotecan Inhibitor 95.26% Phase 1
HY-136789 Tuxobertinib Inhibitor 99.88% Phase 1
HY-15196 TAK-285 Inhibitor 98.99% Phase 1
HY-103443 HKI-357 Inhibitor 99.24% Phase 1
HY-B0794 AZ7550 Inhibitor 97.09% Phase 1
HY-116437 Selatinib Inhibitor 98.56% Phase 1
HY-155079 DZD1516 99.62% Phase 1
HY-10346 AV-412 Inhibitor 99.17% Phase 1
HY-101820 Simotinib Inhibitor 99.39% Phase 1
HY-153110 Larotinib Inhibitor 99.50% Phase 1
HY-139300 Epitinib Inhibitor 99.95% Phase 1
HY-164694 Emupertinib Inhibitor 99.10% Phase 1
HY-171747 AMT-562 Antagonist 98.65% Phase 1
HY-177895 IAM1363 Inhibitor 99.40% Phase 1
HY-111553 TAS0728 Inhibitor 99.71% Phase 1
HY-128778 Gozanertinib Inhibitor 98.37% Phase 1
HY-164307 Pebezertinib Inhibitor 99.56% Phase 1
HY-15732 BGB-102 Inhibitor 99.52% Phase 1
HY-164464 BPI-15086 Inhibitor / Phase 1
HY-104066A Theliatinib tartrate / Phase 1
HY-181954 ZW-49 Inhibitor / Phase 1
HY-177710 MEDI4276 / Phase 1
HY-110039 BIBX 1382 dihydrochloride Inhibitor / Phase 1
HY-153856 TAS2940 Inhibitor / Phase 1
HY-110333 BMS-599626 dihydrochloride Inhibitor / Phase 1
Inhibitory Antibodies (49)
Cat. No. Product Name Effect
Purity Phase
HY-P99041A Panitumumab (anti-EGFR) Inhibitor 99.02% Phase 4
HY-P99969 Inetetamab Inhibitor 96.54% Phase 4
HY-P99854A Disitamab (powder) Inhibitor 98.44% Phase 4
HY-P99041B Panitumumab (powder) Inhibitor / Phase 4
HY-P99275 Patritumab Inhibitor 99.28% Phase 3
HY-P99406 Petosemtamab Degrader 99.94% Phase 3
HY-P99676 Izalontamab Inhibitor 99.89% Phase 3
HY-P99849 Depatuxizumab Inhibitor 99.58% Phase 3
HY-P99155 Zalutumumab 98.34% Phase 3
HY-P990049 Becotatug Inhibitor 99.00% Phase 3
HY-P99437 Anbenitamab Inhibitor 99.22% Phase 3
HY-P99455 Bafisontamab Inhibitor 99.9% Phase 3
HY-P990697 Anvatabart Inhibitor 98.15% Phase 3
HY-P99831 Coprelotamab / Phase 3
HY-P99630 Gancotamab antibody Inhibitor ≥99.0% Phase 3
HY-P991588 HLX-22 Antagonist 99.47% Phase 3
HY-P991508 Sym004 Inhibitor 98.97% Phase 3
HY-P99155A Zalutumumab (powder) Inhibitor / Phase 3
HY-P99268 Seribantumab Inhibitor 96.043% Phase 2
HY-P9969 Matuzumab 98.12% Phase 2
HY-P99936 Elgemtumab Inhibitor 99.00% Phase 2
HY-P99778 Ontuxizumab 99.85% Phase 2
HY-P990314 AFM24 Inhibitor 96.26% Phase 2
HY-P99295 Imgatuzumab Inhibitor 99.41% Phase 2
HY-P990071 Fepixnebart Inhibitor 96.46% Phase 2
HY-P99605 Cinrebafusp alfa Inhibitor 98.53% Phase 2
HY-P99306 Modotuximab Inhibitor 99.08% Phase 2
HY-P99628 Futuximab Inhibitor 98.09% Phase 2
HY-P991237 Nezutatug Inhibitor 99.9% Phase 2
HY-P991571 GC1118 99.22% Phase 2
HY-P990913 Dalmitamig 97.158% Phase 2
HY-P99672 Istiratumab Inhibitor 98.45% Phase 2
HY-P991238 MEDI4276 Antibody Inhibitor 96.5212% Phase 2
HY-P9994 Pertuzumab zuvotolimod Inhibitor 98.64% Phase 2
HY-P991240 CDX-3379 Inhibitor 99.38% Phase 2
HY-P991507 SCT200 Inhibitor 99.09% Phase 2
HY-P991092 IBI-334 Inhibitor 98.18% Phase 2
HY-P991233 BAT1006 Inhibitor / Phase 2
HY-P991524 MM-111 Inhibitor / Phase 2
HY-P991572 MM-151 Antagonist / Phase 2
HY-P99500 Cetuximab sarotalocan Inhibitor / Phase 2
HY-P99896 Runimotamab 99.00% Phase 1
HY-P99386 Vesencumab Inhibitor 99.34% Phase 1
HY-P99304 Lumretuzumab Inhibitor ≥99.0% Phase 1
HY-P99685 Laprituximab emtansine Inhibitor 97.66% Phase 1
HY-P991244 REGN-1400 Inhibitor / Phase 1
HY-P991984 SIBP-03 Inhibitor / Phase 1
HY-P991235 FS102 Degrader / Phase 1
HY-P990609 KHK-2866 98.23% Phase 1

Pre-clinical Phase

Bioactive Molecules (927)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-12000 AG490 Inhibitor 99.86% Unkown
HY-P0221 PACAP (1-38), human, ovine, rat Inducer 99.99% Unkown
HY-13524 AG-1478 Inhibitor 99.57% Unkown
HY-P10408 Candidalysin Activator 99.81% Unkown
HY-101084 NSC 228155 Activator 99.58% Unkown
HY-164992 Trastuzumab vedotin Inhibitor 98.05% Unkown
HY-13595 Chrysophanol Inhibitor 99.73% Unkown
HY-N0280 Corosolic acid 99.89% Unkown
HY-16558 Butein Inhibitor 99.64% Unkown
HY-N2409 Delphinidin chloride Inhibitor 98.0% Unkown
HY-171135 Cetuximab MMAE Inhibitor 99.64% Unkown
HY-100848 TX1-85-1 Inhibitor 99.65% Unkown
HY-12461 WS6 Activator 99.30% Unkown
HY-100958 4-DAMP Inhibitor 99.96% Unkown
HY-B0793 AZ-5104 Inhibitor 99.91% Unkown
HY-156698 HJM-561 Degrader 99.52% Unkown
HY-N7922 Urolithin M5 97.31% Unkown
HY-123921 Gefitinib-based PROTAC 3 Inhibitor 99.98% Unkown
HY-19816 Avitinib Inhibitor 99.95% Unkown
HY-15644 Tyrphostin 23 Inhibitor 98.19% Unkown
HY-168438 ERBB agonist-1 Agonist 99.16% Unkown
HY-14596R Genistein (Standard) Inhibitor 98.70% Unkown
HY-N0447 8-Gingerol Inhibitor 99.82% Unkown
HY-108052 Delphinidin 3-glucoside chloride Inhibitor 99.89% Unkown
HY-162713 MTX-531 Inhibitor 99.87% Unkown
HY-120852 JG26 Inhibitor 98.14% Unkown
HY-112411 PD 174265 Inhibitor 98.35% Unkown
HY-W016412 Coenzyme Q0 Inhibitor 99.79% Unkown
HY-129550 BI-4020 Inhibitor 99.30% Unkown
HY-13896 PD168393 Inhibitor 98.01% Unkown
HY-41404 Piperonylic acid 99.94% Unkown
HY-109189 Rezivertinib Inhibitor 99.62% Unkown
HY-48999A FSK hydrochloride 99.97% Unkown
HY-131864 SJF-1528 Degrader 98.90% Unkown
HY-100434 PD-161570 Inhibitor 98.78% Unkown
HY-141640 MS154 Inhibitor 99.71% Unkown
HY-138751 limertinib Inhibitor 99.12% Unkown
HY-N2450 Sulforaphene Inhibitor 99.78% Unkown
HY-N0211 Cyasterone Inhibitor 99.58% Unkown
HY-18609 PD158780 Inhibitor 99.47% Unkown
HY-W782083 p-SCN-Bn-NOTA trihydrochloride 99.75% Unkown
HY-155736 MAPK-IN-2 Inhibitor 99.66% Unkown
HY-125168 EGA Modulator 99.76% Unkown
HY-N2184 Furanodienone 99.90% Unkown
HY-14596S Genistein-d4 Inhibitor 98.81% Unkown
HY-10530 Varlitinib Inhibitor 99.92% Yes
HY-N7005 Clitorin Inhibitor 99.45% Unkown
HY-141676 HyT36 Degrader 96.0% Unkown
HY-15375 Allitinib Inhibitor 98.88% Unkown
HY-100213 EAI045 Inhibitor 99.06% Unkown
HY-N0891 Tubeimoside II Inhibitor 99.90% Unkown
HY-10322 Falnidamol Inhibitor 99.41% Unkown
HY-138916 PF-06672131 Inhibitor 99.47% Unkown
HY-157229 STX-721 Inhibitor 98.25% Unkown
HY-10367A Canertinib dihydrochloride Inhibitor 99.68% Unkown
HY-156712 Depatuxizumab MMAE Inhibitor 99.73% Unkown
HY-20878 Tyrphostin AG 879 Inhibitor 99.26% Unkown
HY-115605 CN009543V Agonist 99.37% Unkown
HY-N9330 Broussoflavonol F Inhibitor 98.11% Unkown
HY-10261B (E/Z)-Afatinib Inhibitor 99.98% Unkown
HY-B0794B AZ7550 Mesylate Inhibitor 98.70% Unkown
HY-18963 Lavendustin A Inhibitor 98.95% Unkown
HY-131865 SJF-1521 Degrader 99.65% Unkown
HY-N2524 Camelliaside A Ligand 99.65% Unkown
HY-123578 NSC689857 Inhibitor 99.49% Unkown
HY-161536 PROTAC EGFR degrader 9 Inhibitor 98.35% Unkown
HY-124813 PDZ1i Inhibitor 99.29% Unkown
HY-N2510 Myristicin Inhibitor 99.89% Unkown
HY-104066 Theliatinib Inhibitor 99.72% Unkown
HY-109061B Lazertinib mesylate Inhibitor 99.85% Unkown
HY-108016 Peruvoside Inhibitor 99.32% Unkown
HY-157581 MS39 Degrader 99.89% Unkown
HY-108484 PP 3 Inhibitor 99.20% Unkown
HY-10325 CL-387785 Inhibitor 99.31% Unkown
HY-134877 BAY 2476568 Inhibitor 99.88% Unkown
HY-13464 ALK-IN-1 Inhibitor 99.42% Unkown
HY-12026 WZ4002 Inhibitor 98.99% Unkown
HY-112097 E260 Inhibitor 99.92% Unkown
HY-137191 CH7233163 Inhibitor 99.41% Unkown
HY-115481 EphB1-IN-1 Inhibitor 99.51% Unkown
HY-147858 PROTAC EGFR degrader 7 Degrader 99.48% Unkown
HY-N2445 Flavokawain C Inhibitor 99.79% Unkown
HY-150611 EGFR-IN-70 Inhibitor 98.12% Unkown
HY-19729 Naquotinib Inhibitor 98.10% Unkown
HY-107364 MTX-211 Inhibitor 99.81% Unkown
HY-172429 Enozertinib Inhibitor 98.86% Unkown
HY-147219A SIAIS164018 hydrochloride Degrader 98.06% Unkown
HY-103442 CGP52411 Inhibitor 99.82% Unkown
HY-156640 Rocbrutinib Inhibitor 99.76% Unkown
HY-N4201 β-Hydroxyisovalerylshikonin Inhibitor 99.83% Unkown
HY-15772S Osimertinib-d6 Inhibitor 99.70% Unkown
HY-128862 EGFR-IN-7 Inhibitor 99.76% Unkown
HY-128576 DS21360717 99.80% Unkown
HY-12013 PD153035 Hydrochloride Inhibitor 99.48% Unkown
HY-17499 EGFR-IN-12 Inhibitor 99.60% Unkown
HY-15844 AG-825 Inhibitor 98.13% Unkown
HY-13895 WHI-P154 Inhibitor 98.77% Unkown
HY-B1394 Khellin Inhibitor 99.66% Unkown
HY-W018800 4(3H)-Quinazolinone Inhibitor 99.89% Unkown
HY-163094 EGFR-IN-95 Inhibitor 98.76% Unkown
HY-162299 EGFR kinase inhibitor 3 Inhibitor 99.03% Unkown
HY-13897 CNX-2006 Inhibitor 98.00% Unkown
HY-12001 WZ-3146 Inhibitor 99.28% Unkown
HY-161275 BI-4732 Inhibitor 99.30% Unkown
HY-111415 EGFR-IN-5 Inhibitor 99.49% Unkown
HY-147183B JBJ-09-063 hydrochloride Inhibitor 99.37% Unkown
HY-12010 BMS-599626 Hydrochloride Inhibitor 98.90% Unkown
HY-147941A MS9427 TFA Degrader 98.38% Unkown
HY-130616 EGFR-IN-11 Inhibitor 98.76% Unkown
HY-153796 PROTAC Her3 Degrader-8 Degrader 99.60% Unkown
HY-144304 PROTAC EGFR degrader 2 Inhibitor 95.09% Unkown
HY-172470 DSPE-PEG2000-GE11 95.29% Unkown
HY-161408 GePhos1 98.88% Unkown
HY-18603 FIIN-3 Inhibitor 99.01% Unkown
HY-13427 Allitinib tosylate Inhibitor 99.54% Unkown
HY-139617 Sec61-IN-3 Inhibitor 99.22% Unkown
HY-147942 MS9449 98.95% Unkown
HY-136430 JCN037 Inhibitor 99.09% Unkown
HY-175252 PROTAC EGFR degrader 14 Degrader 99.26% Unkown
HY-P2503 EGFR Protein Tyrosine Kinase Substrate 99.46% Unkown
HY-P5314 OK2 Inhibitor 99.13% Unkown
HY-161633 PROTAC EGFR degrader 11 Degrader 99.20% Unkown
HY-117155 PKI-166 Inhibitor 98.92% Unkown
HY-110406 13(S)-HPODE Activator 95.05% Unkown
HY-101960A Tyrphostin A51 Inhibitor 99.0% Unkown
HY-161537 EGFR ligand-9 Inhibitor 98.80% Unkown
HY-146349 PROTAC EGFR degrader 4 Degrader 99.70% Unkown
HY-N1073 Wighteone Inhibitor 98.71% Unkown
HY-N1988 Cucurbitacin IIa Inhibitor 99.90% Unkown
HY-149530 EGFR-IN-86 Inhibitor 99.92% Unkown
HY-153901 PROTAC EGFR degrader 8 Degrader 98.90% Unkown
HY-43533 Tarlox-TKI Inhibitor 98.79% Unkown
HY-P4082 ErbB-2-binding peptide-1 Ligand 99.52% Unkown
HY-163428 Perzebertinib Inhibitor / Unkown
HY-12029 WZ8040 Inhibitor 98.29% Unkown
HY-150023 BI-1622 Inhibitor 98.02% Unkown
HY-138627A AST5902 trimesylate Inhibitor 98.75% Unkown
HY-147183A JBJ-09-063 TFA Inhibitor 99.64% Unkown
HY-175839 PROTAC EGFR degrader 15 Degrader 99.23% Unkown
HY-P11308 Cys-GE11 98.03% Unkown
HY-103440 EGFR/ErbB-2/ErbB-4 inhibitor-3 Inhibitor 96.78% Unkown
HY-79511 FAAH-IN-2 Ligand 99.12% Unkown
HY-19985A (3S,4S)-PF-06459988 98.97% Unkown
HY-123035 Gamendazole Inhibitor 99.44% Unkown
HY-RS04209 EGFR Human Pre-designed siRNA Set A Inhibitor / Unkown
HY-161126 EGFR-IN-98 Inhibitor 99.12% Unkown
HY-P10792 HER2-targeted peptide H6F 98.85% Unkown
HY-101219 VEGFR-IN-1 Inhibitor 99.07% Unkown
HY-W013857 Lavendustin C Inhibitor 98.17% Unkown
HY-157579 MS154N 99.30% Unkown
HY-15336 AG 555 Inhibitor 98.0% Unkown
HY-103566 LY456236 Inhibitor 99.57% Unkown
HY-112293 GW2974 99.16% Unkown
HY-177008 PROTAC HER2 degrader-1 Degrader 98.0% Unkown
HY-123952 RTC-5 Inhibitor 99.37% Unkown
HY-124674A CCT365623 hydrochloride Inhibitor 98.07% Unkown
HY-P1828A EGFRvIII peptide (PEPvIII) TFA 98.73% Unkown
HY-101429 RG13022 Inhibitor 96.74% Unkown
HY-101041 (E)-AG 556 Inhibitor 99.91% Unkown
HY-164919 Calotatug ginistinag Inhibitor 95.94% Unkown
HY-126320 EGFR-IN-8 Inhibitor 98.01% Unkown
HY-15769 WHI-P180 Inhibitor 99.84% Unkown
HY-150024 BI-4142 Inhibitor 98.02% Unkown
HY-142283AS Dosimertinib-d5 mesylate Inhibitor 99.50% Unkown
HY-100214 EAI001 Inhibitor 99.93% Unkown
HY-101042 AG-494 Inhibitor 98.69% Unkown
HY-156284 EGFR-IN-89 Inhibitor 98.75% Unkown
HY-101450 PF-6274484 Inhibitor 98.76% Unkown
HY-112420 EGFR/ErbB-2-IN-2 Inhibitor 99.45% Unkown
HY-P10224A G7-18NATE TFA 98.06% Unkown
HY-12806 AG1557 Inhibitor 99.54% Unkown
HY-N6577 Astragaloside VI 99.95% Unkown
HY-N7424 4,7-Dihydroxycoumarin Inhibitor 98.25% Unkown
HY-172920 Wnt/β-catenin-IN-6 Inhibitor 98.34% Unkown
HY-157480 EGFR/AURKB-IN-1 Inhibitor 99.43% Unkown
HY-15729A Rociletinib hydrobromide Inhibitor 98.04% Yes
HY-107459 (E/Z)-AG490 Inhibitor 99.71% Unkown
HY-13984 NT-1 Inhibitor 99.40% Unkown
HY-N6932 Voacamine 99.64% Unkown
HY-135805B (Rac)-JBJ-04-125-02 acetate 96.58% Unkown
HY-112474 Tyrphostin AG 112 Inhibitor 98.31% Unkown
HY-111138 CZC-8004 Inhibitor 99.81% Unkown
HY-118532 Tyrphostin AG30 Inhibitor 98.51% Unkown
HY-142512 EGFR-IN-24 Inhibitor 98.71% Unkown
HY-131864A SJF-1528 hemihydrate Degrader 98.90% Unkown
HY-119944 JND3229 Inhibitor 99.38% Unkown
HY-153110A Larotinib mesylate hydrate Inhibitor 98.66% Unkown
HY-141481 DP-C-4 Inhibitor 98.15% Unkown
HY-143337 EGFR-IN-47 Inhibitor 96.01% Unkown
HY-149889 EGFR-IN-78 Inhibitor 99.57% Unkown
HY-156741A EGFR-IN-87 hydrochloride Inhibitor 98.0% Unkown
HY-103441 JNJ28871063 hydrochloride Inhibitor 98.36% Unkown
HY-161927 EGFR-TK-IN-4 Inhibitor 99.90% Unkown
HY-133780 Afatinib impurity 11 Inhibitor 99.10% Unkown
HY-50896S Erlotinib-d6 Inhibitor 99.84% Unkown
HY-P1855 HER2/neu (654-662) GP2 98.26% Unkown
HY-15801 HG-14-10-04 Inhibitor 98.53% Unkown
HY-145960A MC-Val-Cit-PAB-Amide-TLR7 agonist 4 formic Agonist 97.70% Unkown
HY-100064 O-Desmethyl gefitinib Inhibitor 99.40% Unkown
HY-112345 PD-089828 Inhibitor 98.07% Unkown
HY-101522 CHMFL-EGFR-202 Inhibitor 99.75% Unkown
HY-161781 HVH-2930 Inhibitor 96.54% Unkown
HY-101426 RG14620 Inhibitor 99.02% Unkown
HY-P11078A LARLLT TFA 99.89% Unkown
HY-RS04466 ERBB2 Human Pre-designed siRNA Set A Inhibitor / Unkown
HY-172414 Andamertinib Inhibitor 99.06% Unkown
HY-164763 SHR-A1201 Inhibitor 97.35% Unkown
HY-170820 XYD049 Inhibitor 99.46% Unkown
HY-179572 STA-013 Inhibitor 99.18% Unkown
HY-139997 DDC-01-163 Degrader 99.05% Unkown
HY-N1166 Tephrosin 98.02% Unkown
HY-158149 T-1-PMPA Inhibitor 99.70% Unkown
HY-162890 EGFR-IN-122 Inhibitor 99.98% Unkown
HY-131686A Ganglioside GT1b (porcine) ammonium Activator 98% Unkown
HY-RS04472 ERBB4 Human Pre-designed siRNA Set A Inhibitor / Unkown
HY-101006 Methyl 2,5-dihydroxycinnamate Inhibitor 99.77% Unkown
HY-151159 DHFR-IN-4 Inhibitor 99.19% Unkown
HY-100923 H-9 Dihydrochloride Inhibitor 98.98% Unkown
HY-50898S Lapatinib-d4 Inhibitor 99.02% Unkown
HY-13450 ZM 449829 Inhibitor 99.73% Unkown
HY-157582 MS39N Control 98.0% Unkown
HY-156872 MTX-216 Inhibitor / Unkown
HY-50895S2 Gefitinib-d3 Inhibitor 98.39% Unkown
HY-113599 Isoprocurcumenol Activator 95.41% Unkown
HY-112870AS Firmonertinib-d3 mesylate 99.00% Unkown
HY-50895S Gefitinib-d8 Inhibitor 98.42% Unkown
HY-100962 (E)-AG 99 Inhibitor 98.12% Unkown
HY-19617 EGFR-IN-1 Inhibitor / Unkown
HY-131067 EMI56 Inhibitor 99.36% Unkown
HY-19617A EGFR-IN-1 hydrochloride Inhibitor / Unkown
HY-135805A (Rac)-JBJ-04-125-02 Inhibitor / Unkown
HY-132842A (S)-Sunvozertinib Inhibitor 99.05% Unkown
HY-115716 EGFR-IN-17 Inhibitor 98.18% Unkown
HY-147183 JBJ-09-063 Inhibitor / Unkown
HY-147941 MS9427 Degrader 95.29% Unkown
HY-152852 Mefatinib free base Inhibitor 99.40% Unkown
HY-139300A Epitinib succinate Inhibitor 99.01% Unkown
HY-130608 Mutated EGFR-IN-3 Inhibitor / Unkown
HY-138627 AST5902 Inhibitor / Unkown
HY-103439 GW583340 dihydrochloride Inhibitor / Unkown
HY-12872B Nazartinib S-enantiomer 95.10% Unkown
HY-14347 EBE-A22 Control 99.76% Unkown
HY-131088A N3-PEG8-Phe-Lys-PABC-Gefitinib TFA Inhibitor / Unkown
HY-126319 SU5204 Inhibitor 99.46% Unkown
HY-155285 YS-363 Inhibitor 99.52% Unkown
HY-P2673A Lys-Arg-Thr-Leu-Arg-Arg acetate / Unkown
HY-10346A AV-412 free base Inhibitor 98.10% Unkown
HY-150610 EGFR-IN-69 Inhibitor 99.58% Unkown
HY-145960 MC-Val-Cit-PAB-Amide-TLR7 agonist 4 Agonist 99.39% Unkown
HY-183068 AP4-43 Inhibitor 99.76% Unkown
HY-144677 pan-HER-IN-2 Inhibitor 98.10% Unkown
HY-12008S Erlotinib-d6 hydrochloride Inhibitor 98.13% Unkown
HY-164387 Sutetinib Inhibitor 99.27% Unkown
HY-155358 Os30 Inhibitor 98.34% Unkown
HY-P2673 Lys-Arg-Thr-Leu-Arg-Arg / Unkown
HY-162254 EGFR/ACK1-IN-1 Inhibitor 98.19% Unkown
HY-149636 Multi-target kinase inhibitor 2 Inhibitor 99.82% Unkown
HY-100499 Tyrphostin AG 528 Inhibitor 98.0% Unkown
HY-170928 DA-0157 Inhibitor 99.59% Unkown
HY-158310 SOS1/EGFR-IN-1 Inhibitor 99.54% Unkown
HY-131088 N3-PEG8-Phe-Lys-PABC-Gefitinib Inhibitor / Unkown
HY-183682 AZ14289671 Inhibitor 98.99% Unkown
HY-126850 4-Epidoxycycline / Unkown
HY-E70715 ERBB2 775YVMA776 Recombinant Human Active Protein Kinase / Unkown
HY-129510 4-Methyl erlotinib Inhibitor 99.34% Unkown
HY-161618 MJ04 Inhibitor 98.08% Unkown
HY-147219 SIAIS164018 Degrader / Unkown
HY-138072 EMI1 Inhibitor 99.45% Unkown
HY-N6651 Isocryptotanshinone Inhibitor ≥98.0% Unkown
HY-156741 EGFR-IN-87 Inhibitor / Unkown
HY-101007A (+)-Tyrphostin B44 Inhibitor 99.10% Unkown
HY-108931 AG 1406 Inhibitor 99.03% Unkown
HY-156912 Tyrosine kinase-IN-7 Inhibitor 99.25% Unkown
HY-157413 YS-67 Inhibitor 99.41% Unkown
HY-13272S2 Dacomitinib-d10 dihydrochloride Inhibitor ≥95.0% Unkown
HY-U00002 ZD-4190 Inhibitor 98.08% Unkown
HY-151048 JBJ-07-149 Inhibitor 99.09% Unkown
HY-147858A PROTAC EGFR degrader 7 diTFA Degrader 97.15% Unkown
HY-155005 EGFR mutant-IN-2 Inhibitor 97.0% Unkown
HY-50895S1 Gefitinib-d6 Inhibitor 98.2% Unkown
HY-111452 EGFR-IN-85 Inhibitor / Unkown
HY-P3744 pp60v-src Autophosphorylation site 99.93% Unkown
HY-15772S1 Osimertinib-13C,d3 99.14% Unkown
HY-N10103 Neoschaftoside Modulator 98.04% Unkown
HY-101958 Tyrphostin 25 Inhibitor 99.00% Unkown
HY-B0794A AZ7550 hydrochloride Inhibitor 98.66% Unkown
HY-10261S Afatinib-d6 Inhibitor 99.0% Unkown
HY-15772S3 Asandeutertinib Inhibitor 99.75% Unkown
HY-19617B EGFR-IN-1 TFA Inhibitor 99.38% Unkown
HY-135805 JBJ-04-125-02 Inhibitor / Unkown
HY-153111 EGFR/HER2-IN-9 Inhibitor 98.73% Unkown
HY-164476 ES-072 Inhibitor 98.05% Unkown
HY-12872A Nazartinib mesylate Inhibitor / Unkown
HY-21291 SU-4313 Modulator 99.31% Unkown
HY-123766 EGFR-IN-99 Inhibitor 98.09% Unkown
HY-W109039 EGFR ligand-15 97.03% Unkown
HY-W001520 1-Methyl-1H-pyrrolo[2,3-b]pyridine / Unkown
HY-B0794S AZ7550-d5 Inhibitor / Unkown
HY-185832 SYS6010 Inhibitor / Unkown
HY-142283 Dosimertinib Inhibitor / Unkown
HY-18750A Zorifertinib hydrochloride Inhibitor / Unkown
HY-135914 JBJ-02-112-05 Inhibitor / Unkown
HY-185816 TQB2102 Inhibitor / Unkown
HY-100520 EGFR-IN-2 Inhibitor / Unkown
HY-19981B Derazantinib dihydrochloride Inhibitor / Unkown
HY-144048 EGFR-IN-31 / Unkown
HY-112806 ST8155AA1 / Unkown
HY-168968S ZJY-54 Inhibitor / Unkown
HY-132883 EGFR/CSC-IN-1 Inhibitor / Unkown
HY-143734 HER2-IN-6 / Unkown
HY-B0793S1 AZ-5104-d2 Inhibitor / Unkown
HY-163354 EGFR-IN-103 Inhibitor / Unkown
HY-128860 Mutated EGFR-IN-2 Inhibitor / Unkown
HY-125841 EGFR mutant-IN-1 Inhibitor / Unkown
HY-139920A Oritinib mesylate Inhibitor / Unkown
HY-10407G SU 5402 (GMP) Inhibitor / Unkown
HY-138746 EGFR-IN-15 Inhibitor 96.21% Unkown
HY-147303 Sacibertinib Inhibitor / Unkown
HY-131066 EMI48 Inhibitor 99.02% Unkown
HY-115951 EGFR/HER2-IN-2 Inhibitor / Unkown
HY-147407 Imbotolimod Inhibitor / Unkown
HY-123726 ErbB-1/ErbB-2 tyrosine kinase-IN-1 / Unkown
HY-152852A Mefatinib Inhibitor 98.90% Unkown
HY-137433A Befotertinib mesylate Inhibitor / Unkown
HY-175297 EGFR T790M/VEGFR-2-IN-1 Inhibitor / Unkown
HY-RS04469 ERBB3 Human Pre-designed siRNA Set A Inhibitor / Unkown
HY-144760 EGFR-IN-3 Inducer / Unkown
HY-157399 EGFR/HER2-IN-10 Inhibitor / Unkown
HY-173520 EGFR/HDAC-IN-1 Inhibitor / Unkown
HY-146239 EGFR/HER2/TS-IN-2 Inhibitor / Unkown
HY-144044 EGFR-IN-30 Inhibitor / Unkown
HY-P10224 G7-18NATE / Unkown
HY-172966 EG31 Inhibitor / Unkown
HY-149401 EGFR-IN-82 Inhibitor / Unkown
HY-174232 EGFR/CA-IX-IN-1 Inhibitor / Unkown
HY-163632 EGFR-IN-112 Inhibitor / Unkown
HY-178353 EGFR/Cytokine-IN-1 Inhibitor / Unkown
HY-161031 EGFR-IN-93 Inhibitor / Unkown
HY-182031 JS04 Inhibitor / Unkown
HY-170497 EGFR-IN-140 Inhibitor / Unkown
HY-170665 EGFR T790M/L858R-IN-9 Inhibitor / Unkown
HY-E70711 EGFR T790M/L858R Recombinant Human Active Protein Kinase / Unkown
HY-155969 EGFR-IN-83 Inhibitor / Unkown
HY-163402 EGFR-IN-108 chloride Inhibitor / Unkown
HY-163377 AZ5385 Inhibitor / Unkown
HY-159519 EGFR/HER2-IN-16 Inhibitor / Unkown
HY-146473 EGFR-IN-53 Inhibitor / Unkown
HY-P11757 Cyclo[K(N3)larllt] Ligand / Unkown
HY-146325 HSP90-IN-11 Degrader / Unkown
HY-163723 EGFR-IN-116 Inhibitor / Unkown
HY-147796 EGFR/HER2/CDK9-IN-1 Inhibitor / Unkown
HY-146138 EGFR-IN-57 Inhibitor / Unkown
HY-145844 EGFR-IN-44 Inhibitor / Unkown
HY-164399 SST0116CL1 Degrader / Unkown
HY-156457 EGFR-IN-90 Inhibitor / Unkown
HY-E70698 EGFR d746-750/C797S Recombinant Human Active Protein Kinase / Unkown
HY-147994 EGFR/HER2-IN-5 Inhibitor / Unkown
HY-103437 EGFR-IN-80 Inhibitor / Unkown
HY-162482 EGFR kinase inhibitor 5 Inhibitor / Unkown
HY-162099 VEGFR-IN-4 Inhibitor / Unkown
HY-50898S5 Lapatinib-13C,d7 Inhibitor / Unkown
HY-100636A Gefitinib N-oxide hydrochloride Inhibitor / Unkown
HY-157402 Topoisomerase II/EGFR-IN-1 / Unkown
HY-178157 Multi-target kinase-IN-7 Inhibitor / Unkown
HY-171884 BI-8128 Inhibitor / Unkown
HY-157398 EGFR T790M/L858R-IN-3 Inhibitor / Unkown
HY-E70699 EGFR d746-750/T790M/C797S Recombinant Human Active Protein Kinase / Unkown
HY-18957A rel-Lifirafenib Control / Unkown
HY-P5742A ELAAWCRWGFLLALLPPGIAG TFA / Unkown
HY-112334 EGFR-IN-198 Inhibitor / Unkown
HY-170559 EGFR-IN-141 Inhibitor / Unkown
HY-178119 HER4/HER2-IN-1 Inhibitor / Unkown
HY-110328 PKI-166 hydrochloride Inhibitor / Unkown
HY-P11760 HER2-targeted peptide H10 Ligand / Unkown
HY-172091 CZY43 Degrader / Unkown
HY-169408 EGFR-IN-137 Inhibitor / Unkown
HY-P11752 Cyclo(KLARLLT) Ligand / Unkown
HY-161136 EGFR/STAT3-IN-1 Inhibitor / Unkown
HY-185276 EGFR-IN-204 Inhibitor 98.57% Unkown
HY-161923 EGFR-IN-120 Inhibitor / Unkown
HY-164503 Neptinib Inhibitor / Unkown
HY-185227 EphB4-IN-1 Inhibitor / Unkown
HY-170438 EGFR-IN-139 / Unkown
HY-184274 EGFR/c-SRC-IN-1 Inhibitor / Unkown
HY-155200 EGFR-IN-84 Inhibitor / Unkown
HY-175820 AGW-11 Inhibitor / Unkown
HY-142679 EGFR-IN-22 Inhibitor / Unkown
HY-178009 EGFR-IN-175 Inhibitor / Unkown
HY-162623 EGFR/HER2-IN-15 Inhibitor / Unkown
HY-183090 EGFR/VEGFR2-IN-13 Inhibitor / Unkown
HY-179148 EGFR-IN-184 Inhibitor / Unkown
HY-181829 Ctx-L3 Degrader / Unkown
HY-RS04470 Erbb3 Mouse Pre-designed siRNA Set A Inhibitor / Unkown
HY-172471 DSPE-PEG5000-GE11 / Unkown
HY-157994 EGFR WT/T790M-IN-2 Inhibitor / Unkown
HY-161731 DS08701581 Inhibitor / Unkown
HY-180949 EGFR-IN-189 Inhibitor / Unkown
HY-144050 EGFR-IN-33 Inhibitor / Unkown
HY-149518 EGFR/BRAFV600E-IN-3 Inhibitor / Unkown
HY-150908 Brigatinib A Ligand / Unkown
HY-100663 Gefitinib impurity 2 99.56% Unkown
HY-176556 EGFR-IN-167 Inhibitor / Unkown
HY-144055 EGFR-IN-38 Inhibitor / Unkown
HY-147741 DPPY Inhibitor / Unkown
HY-P11944 Peptide 22 Chemical / Unkown
HY-178939 EGFR-IN-181 Inhibitor / Unkown
HY-144445 NSC114126 Inhibitor / Unkown
HY-19730A Olmutinib hydrochloride Inhibitor / Unkown
HY-172111 EGFR-IN-144 Inhibitor / Unkown
HY-175171 Anticancer agent 276 Inhibitor / Unkown
HY-162964 EGFR-IN-126 Inhibitor / Unkown
HY-144051 EGFR-IN-34 Inhibitor / Unkown
HY-142283BS N-Desmethyl dosimertinib-d5 / Unkown
HY-152852S Mefatinib-d6 free base Inhibitor / Unkown
HY-156033 EGFR-IN-88 Inhibitor / Unkown
HY-169568 EGFR-IN-147 Inhibitor / Unkown
HY-13050A Sapitinib fumarate Inhibitor / Unkown
HY-183253 DL149 Ligand / Unkown
HY-180196 EGFR-IN-187 Inhibitor / Unkown
HY-147997 EGFR-IN-68 Inhibitor / Unkown
HY-138627B AST5902 mesylate Inhibitor / Unkown
HY-168073 EGFR/VEGFR2-IN-1 Inhibitor / Unkown
HY-182742 EGFR-IN-208 Inhibitor / Unkown
HY-158154 EGFR-IN-110 Inhibitor / Unkown
HY-175011 EGFR-IN-165 Inhibitor / Unkown
HY-172780 EGFR-IN-161 Inhibitor / Unkown
HY-160828 O-Desmethyl dacomitinib Inhibitor / Unkown
HY-149632 EGFR/HER2/DHFR-IN-2 Inhibitor / Unkown
HY-178116 HER2-IN-23 Inhibitor / Unkown
HY-117852 CGP-59326 Inhibitor / Unkown
HY-151981 EGFR-IN-74 Inhibitor / Unkown
HY-169427 FRF-06-057 Inhibitor / Unkown
HY-158153 EGFR-IN-108 Inhibitor / Unkown
HY-180823 Topoisomerase II/EGFR-IN-2 Inhibitor / Unkown
HY-P11484 Myosin Regulatory Light Chain MRCL3 (11-24) / Unkown
HY-RS04473 Erbb4 Mouse Pre-designed siRNA Set A Inhibitor / Unkown
HY-P10686 CH401 peptide / Unkown
HY-178440 EGFR/COX-2-IN-2 Inhibitor / Unkown
HY-168151 EGFR-IN-128 Inhibitor / Unkown
HY-181099 EGFR WT/T790M-IN-4 Inhibitor / Unkown
HY-177380 EGFR ligand-14-PEG3-Boc / Unkown
HY-162788 EGFR-IN-121 Inhibitor / Unkown
HY-131710 PDE5-IN-3 Inhibitor / Unkown
HY-167948 Dacomitinib metabolite M1/2 Inhibitor / Unkown
HY-178442 EGFR-IN-179 Inhibitor / Unkown
HY-183373 EGFR/PARP-1-IN-1 Inhibitor / Unkown
HY-161269 EGFR-IN-101 Inhibitor / Unkown
HY-144441 NSC81111 Inhibitor / Unkown
HY-P10994 Eps8 peptide 327 Inhibitor / Unkown
HY-50898S3 Lapatinib-d4-1 Inhibitor / Unkown
HY-123891 NS-062 Inhibitor / Unkown
HY-181775 VEGFR-2/c-Met/EGFR-IN-1 Inhibitor / Unkown
HY-147996 EGFR-IN-67 Inhibitor / Unkown
HY-177009 Tucatinib analog B Ligand / Unkown
HY-181251 EGFR-IN-195 Inhibitor / Unkown
HY-163000 EGFR-IN-129 Inhibitor / Unkown
HY-152019 EGFR/C797S-IN-1 Inhibitor / Unkown
HY-181923 IMP-Zn / Unkown
HY-112823S Almonertinib-d6 Inhibitor / Unkown
HY-168577 KRAS G12D inhibitor 25 Degrader / Unkown
HY-170543 Dual Galectin-3/EGFR-IN-1 Inhibitor / Unkown
HY-151158 EGFR/HER2-IN-7 Inhibitor / Unkown
HY-179529 EGFR/InhA-IN-1 Inhibitor / Unkown
HY-162881 DS06652923 Inhibitor / Unkown
HY-153605 EGFR-IN-77 Inhibitor / Unkown
HY-147967 EGFR-IN-63 Inhibitor / Unkown
HY-P11078 LARLLT / Unkown
HY-146210 EGFR-IN-50 Inhibitor / Unkown
HY-175162 EGFR ligand-20 Ligand / Unkown
HY-10261AS Afatinib-d6 dimaleate Inhibitor / Unkown
HY-180917 PROTAC EGFR degrader 17 Degrader / Unkown
HY-208666 EGFR-IN-215 Inhibitor / Unkown
HY-P10648 Herceptide / Unkown
HY-180541 EGFR-IN-190 Inhibitor / Unkown
HY-129288 GW837016X Inhibitor / Unkown
HY-172877 EGFR/BRAFV600E-IN-5 Inhibitor / Unkown
HY-P10995 TAT-327 Inhibitor / Unkown
HY-168112 EGFR-IN-127 Inhibitor / Unkown
HY-156639 EGFR/ErbB-2 inhibitor-1 Inhibitor / Unkown
HY-158178 EGFR T790M/L858R-IN-7 Inhibitor / Unkown
HY-156097 Anticancer agent 158 Inhibitor / Unkown
HY-109061A Lazertinib mesylate hydrate Inhibitor / Unkown
HY-179600 Dyrk1A-IN-16 Inhibitor / Unkown
HY-173218 anti-NSCLC agent-1 Inhibitor / Unkown
HY-E70695 EGFR C797S Recombinant Human Active Protein Kinase / Unkown
HY-175173 EGFR-IN-166 Inhibitor / Unkown
HY-146238 EGFR/HER2/TS-IN-1 Inhibitor / Unkown
HY-139884 EGFR-IN-18 Inhibitor / Unkown
HY-168492 TrxR/EGFR-IN-1 Inhibitor / Unkown
HY-173188 EGFR-IN-154 Inhibitor / Unkown
HY-181097 EGFR-IN-192 Inhibitor / Unkown
HY-169216 Multi-target kinase inhibitor 3 Inhibitor / Unkown
HY-185833 ADC Control Human IgG1-JSSW-001 Inhibitor / Unkown
HY-183277 EGFR-IN-209 Inhibitor / Unkown
HY-156470 Multi-kinase-IN-6 Inhibitor / Unkown
HY-182073 EGFR-IN-207 Inhibitor / Unkown
HY-P11761 HYNIC-H10F Ligand / Unkown
HY-179599 Dyrk1A-IN-15 Inhibitor / Unkown
HY-13314A Tesevatinib tosylate Inhibitor / Unkown
HY-172179 EGFR/VEGFR2-IN-5 Inhibitor / Unkown
HY-181701 EGFR-IN-202 Inhibitor / Unkown
HY-172469 DSPE-PEG1000-GE11 / Unkown
HY-175009 MRC-G-001 Inhibitor / Unkown
HY-50896S1 Erlotinib-13C6 Inhibitor / Unkown
HY-172795 EGFR-IN-158 Inhibitor / Unkown
HY-50898S2 Lapatinib-d5 Inhibitor / Unkown
HY-146472 EGFR-IN-52 Inhibitor / Unkown
HY-177270 CHNQD-01281 Modulator / Unkown
HY-169428 EGFR-IN-138 / Unkown
HY-13272S3 Dacomitinib-d10 Inhibitor / Unkown
HY-173038 EGFR-IN-151 Inhibitor / Unkown
HY-180242 EGFR/CDK2-IN-5 Inhibitor / Unkown
HY-143246 EGFR kinase inhibitor 1 Inhibitor / Unkown
HY-172104 EGFR-IN-143 Inhibitor / Unkown
HY-162360 EGFR-IN-109 Inhibitor / Unkown
HY-185815 JSKN003 / Unkown
HY-P10792A HYNIC-H6F Ligand / Unkown
HY-164056 EGFR T790M/L858R-IN-8 Inhibitor 99.20% Unkown
HY-150782 UNC-CA359 Inhibitor / Unkown
HY-147248 Opadotina Inhibitor / Unkown
HY-144052 EGFR-IN-35 Inhibitor / Unkown
HY-180536 HB-EGF-IN-1 Inhibitor / Unkown
HY-144056 EGFR-IN-39 Inhibitor / Unkown
HY-157526 EGFR-TK-IN-1 Inhibitor / Unkown
HY-174231 EGFR-IN-163 Inhibitor / Unkown
HY-155178 Antiproliferative agent-34 Inhibitor / Unkown
HY-178311 EGFR Ligand-Linker Conjugates 4 Ligand / Unkown
HY-138298D Trastuzumab deruxtecan (DAR6) Inhibitor / Unkown
HY-184116 A2AR/EGFR-IN-1 Inhibitor / Unkown
HY-180922 EGFR kinase-IN-8 Inhibitor / Unkown
HY-P5258 Oligopeptide-41 Inducer 98.05% Unkown
HY-E70701 EGFR d747-749/A750P Recombinant Human Active Protein Kinase / Unkown
HY-146136 EGFR-IN-56 Inhibitor / Unkown
HY-163371 EGFR WT/T790M-IN-1 Inhibitor / Unkown
HY-163722 EGFR/DHFR-IN-1 Inhibitor / Unkown
HY-147995 EGFR-IN-64 Inhibitor / Unkown
HY-144794 EGFR-IN-46 Inhibitor / Unkown
HY-164413 CLM3 Inhibitor / Unkown
HY-103439A GW583340 Inhibitor / Unkown
HY-50898S1 Lapatinib-d7 dihydrochloride Inhibitor / Unkown
HY-114535 Jaceidin Inhibitor / Unkown
HY-118175 RG 14921 Inhibitor / Unkown
HY-173118 EGFR-IN-152 Inhibitor / Unkown
HY-168623 EGFR-IN-134 Inhibitor / Unkown
HY-181142 Antitumor agent-213 / Unkown
HY-116504 WB-308 Inhibitor / Unkown
HY-149275 PKM2/PDK1-IN-1 Inhibitor / Unkown
HY-182914 NGI-189 Inhibitor 99.29% Unkown
HY-183123 EGFR T790M/FAK-IN-1 Inhibitor / Unkown
HY-144676 pan-HER-IN-1 Inhibitor / Unkown
HY-176744 HER2-IN-22 Inhibitor / Unkown
HY-175809 SRT6 Inhibitor / Unkown
HY-142519 EGFR-IN-27 Inhibitor / Unkown
HY-151156 EGFR/HER2-IN-6 Inhibitor / Unkown
HY-184301 EGFR/HER2-IN-20 Inhibitor / Unkown
HY-181777 Mal-Pip-ValCit-PAB-AZ7550 Inhibitor / Unkown
HY-E70705 EGFR G719S Recombinant Human Active Protein Kinase / Unkown
HY-163880 EGFR-IN-119 Inhibitor / Unkown
HY-170661 EGFR-IN-142 Inhibitor / Unkown
HY-182005 EGFR/VEGFR2-IN-12 Inhibitor / Unkown
HY-N9684 Degalactotigonin Inhibitor / Unkown
HY-181115 EGFR-IN-193 Inhibitor / Unkown
HY-158175 EGFR T790M/L858R-IN-4 Inhibitor / Unkown
HY-P0221A PACAP (1-38), human, ovine, rat TFA Inducer / Unkown
HY-172160 HER2-IN-21 Inhibitor / Unkown
HY-149824 EGFR T790M/L858R-IN-2 Inhibitor 99.66% Unkown
HY-152144 EGFR-IN-75 Inhibitor / Unkown
HY-163860 EGFR-TK-IN-3 Inhibitor / Unkown
HY-E70708 EGFR L861Q Recombinant Human Active Protein Kinase / Unkown
HY-143445 EGFR-IN-48 Inhibitor / Unkown
HY-159512 EGFR kinase inhibitor 7 Inhibitor / Unkown
HY-168173 EGFR-IN-130 Inhibitor / Unkown
HY-176788 EGFR Ligand-Linker Conjugates 1 Inhibitor / Unkown
HY-17654 BIEGi-1 Inhibitor / Unkown
HY-164392 TAS-121 Inhibitor / Unkown
HY-181714 EGFR-IN-203 Inhibitor / Unkown
HY-181491 Tubulin-IN-64 Inhibitor / Unkown
HY-144605 PROTAC EGFR degrader 3 Inhibitor 97.39% Unkown
HY-168655 EGFR/VEGFR2-IN-3 Inhibitor / Unkown
HY-171958 PROTAC EGFR degrader 12 Degrader / Unkown
HY-P1085 Epidermal Growth Factor Receptor Peptide (985-996) Chemical / Unkown
HY-158018 EGFR-TK-IN-2 Inhibitor / Unkown
HY-175257 Theophylline-platinum(IV) prodrug-1 Inhibitor / Unkown
HY-143733 HER2-IN-5 Inhibitor / Unkown
HY-161891 EGFR/Akt-IN-1 Inhibitor / Unkown
HY-158988 EGFR-IN-114 Inhibitor / Unkown
HY-173500 MG-3C Inhibitor / Unkown
HY-180966 Gly-PEG3-BA Degrader / Unkown
HY-164489 KU004 Inhibitor / Unkown
HY-183788 EGFR-IN-212 Inhibitor / Unkown
HY-168064 EGFR-IN-124 Inhibitor / Unkown
HY-173501 EGFR-IN-157 Inhibitor / Unkown
HY-157166 EGFR kinase inhibitor 2 Inhibitor / Unkown
HY-162332 EGFR-PK/JNK-2-IN-1 Inhibitor / Unkown
HY-W174279 Tyrphostin 8 Inhibitor 98.0% Unkown
HY-168559 EGFR-IN-131 Inhibitor / Unkown
HY-168433 LSD1/EGFR-IN-1 Inhibitor / Unkown
HY-158969 EGFR-IN-113 Inhibitor / Unkown
HY-162300 EGFR kinase inhibitor 4 Inhibitor / Unkown
HY-170787 TZEP7 Inhibitor / Unkown
HY-115952 EGFR/HER2-IN-3 Inhibitor / Unkown
HY-144049 EGFR-IN-32 Inhibitor / Unkown
HY-118900 CP-654577 Inhibitor / Unkown
HY-175588 EGFR-IN-170 Inhibitor / Unkown
HY-175608 EGFR-IN-171 Inhibitor / Unkown
HY-184497 PROTAC EGFR degrader 18 Degrader / Unkown
HY-127067 Yuanhuadin Inhibitor / Unkown
HY-151882 EGFR-IN-73 Inhibitor / Unkown
HY-145823 EGFR-IN-42 Inhibitor / Unkown
HY-178942 EGFR/VEGFR2-IN-9 Inhibitor / Unkown
HY-183754 EGFR-IN-213 Inhibitor / Unkown
HY-181659 EGFR-IN-201 Inhibitor / Unkown
HY-156116 EGFR/CDK2-IN-4 Inhibitor / Unkown
HY-175837 EGFR-IN-172 Inhibitor / Unkown
HY-174415 ZSH-2117 Degrader / Unkown
HY-162062 EGFR WT/T790M/L858R-IN-1 Inhibitor / Unkown
HY-144054 EGFR-IN-37 Inhibitor / Unkown
HY-162148 HNPMI Inhibitor 99.57% Unkown
HY-180154 EGFR/BRAFV600E-IN-6 Inhibitor / Unkown
HY-N3634 Corylifol C / Unkown
HY-175220 4-TCPA Inhibitor / Unkown
HY-147802 EGFR-IN-59 Inhibitor / Unkown
HY-156114 EGFR/CDK2-IN-2 Inhibitor / Unkown
HY-181776 c-Met-IN-31 Inhibitor / Unkown
HY-178448 EGFR-IN-178 Inhibitor / Unkown
HY-P5742 ELAAWCRWGFLLALLPPGIAG / Unkown
HY-146422 PROTAC EGFR degrader 5 Inhibitor / Unkown
HY-149517 EGFR/BRAFV600E-IN-2 Inhibitor / Unkown
HY-172110 Apoptosis inducer 35 Inhibitor / Unkown
HY-175292 EGFR WT/T790M-IN-3 Inhibitor / Unkown
HY-170932 EGFR/COX-2-IN-1 Inhibitor / Unkown
HY-160087 SG3376 Ligand / Unkown
HY-178142 Multi-kinase-IN-7 Inhibitor / Unkown
HY-171443 Lyso-Monosialoganglioside GM3 Inhibitor / Unkown
HY-137786 EGFR-IN-16 Inhibitor / Unkown
HY-161320 EGFR-IN-105 Inhibitor / Unkown
HY-173164 EGFR/BRAFV600E-IN-4 Inhibitor / Unkown
HY-P10793 Cyclic(YCDGFYACYMDV) Inhibitor / Unkown
HY-101960 (Z)-Tyrphostin A51 Inhibitor / Unkown
HY-146782 EGFR-IN-49 Inhibitor / Unkown
HY-147992 EGFR/HER2-IN-4 Inhibitor / Unkown
HY-151377 RET-IN-19 Inhibitor / Unkown
HY-147794 CDK9-IN-41 Inhibitor 98.84% Unkown
HY-178955 EGFR-IN-182 Inhibitor / Unkown
HY-P11781 HW12 Control / Unkown
HY-168170 EGFR/VEGFR2-IN-2 Inhibitor / Unkown
HY-179143 EGFR-IN-185 Inhibitor / Unkown
HY-153744 JGK-068S Inhibitor / Unkown
HY-185460 Pertuzumab-LD3 Inhibitor / Unkown
HY-E70696 EGFR C797S/L858R Recombinant Human Active Protein Kinase / Unkown
HY-147798 EGFR/HER2/CDK9-IN-3 Inhibitor / Unkown
HY-143874 HER2-IN-7 Inhibitor / Unkown
HY-10261E (R)-Afatinib Inhibitor / Unkown
HY-153557A HER2-IN-14 Inhibitor / Unkown
HY-179039 EGFR-IN-183 Inhibitor / Unkown
HY-N16557 (Rac)-8-Gingerol Inhibitor / Unkown
HY-149407 Multi-kinase-IN-4 Inhibitor / Unkown
HY-155118 EGFR-IN-81 Inhibitor / Unkown
HY-116091 EGFR-IN-451 Inhibitor / Unkown
HY-147825 EGFR/BRAFV600E-IN-1 Inhibitor / Unkown
HY-182817 Len-604 Inhibitor / Unkown
HY-163006 EGFR/c-Met-IN-1 Inhibitor / Unkown
HY-155079A (R)-DZD1516 Control 98.80% Unkown
HY-W714853 (+)-Theta-cypermethrin Ligand / Unkown
HY-181766 EGFR/VEGFR2-IN-11 Inhibitor / Unkown
HY-173314 EGFR-IN-155 Inhibitor / Unkown
HY-P11613 DOTA-WC8 Ligand / Unkown
HY-141486A PROTAC PARP/EGFR ligand 1 / Unkown
HY-178313 EGFR ligand-18 Degrader / Unkown
HY-100064S O-Desmethyl gefitinib-d8 Inhibitor 99.84% Unkown
HY-163420 HER2-IN-16 Inhibitor / Unkown
HY-113549 Erbstatin Inhibitor / Unkown
HY-160682 EGFR/HER2-IN-12 Inhibitor / Unkown
HY-158016 Antiproliferative agent-49 Inhibitor / Unkown
HY-116059 EGFR-IN-199 Inhibitor / Unkown
HY-161067 EGFR-IN-96 Inhibitor / Unkown
HY-161785 EGFR-IN-117 Inhibitor / Unkown
HY-15268 PP487 Inhibitor / Unkown
HY-149695 EGFR-IN-91 Inhibitor / Unkown
HY-163417 HER2-IN-15 Inhibitor / Unkown
HY-15772G Osimertinib (GMP) Inhibitor / Unkown
HY-RS04210 Egfr Mouse Pre-designed siRNA Set A Inhibitor / Unkown
HY-168427 Avitinib maleate dihydrate Inhibitor / Unkown
HY-147797 EGFR/HER2/CDK9-IN-2 Inhibitor / Unkown
HY-156991 NODAGA-NHS / Unkown
HY-142681 EGFR-IN-28 Inhibitor / Unkown
HY-146132 EGFR-IN-55 Inhibitor / Unkown
HY-184311 EGFR-IN-214 Inhibitor / Unkown
HY-402309 IGF-1R modulator 1 Modulator / Unkown
HY-143323 HER2-IN-9 Inhibitor / Unkown
HY-175635 EGFR/VEGFR2-IN-6 Inhibitor / Unkown
HY-175531 EGFR-IN-169 Inhibitor / Unkown
HY-158177 EGFR T790M/L858R-IN-6 Inhibitor / Unkown
HY-160613 EGFR/HER2-IN-11 Inhibitor / Unkown
HY-179031 EGFR/VEGFR2-IN-7 Inhibitor / Unkown
HY-163434 PRMT5/EGFR-IN-1 Inhibitor / Unkown
HY-163418 HER2-IN-17 Inhibitor / Unkown
HY-161145 EGFR/microtubule-IN-1 Inhibitor / Unkown
HY-182064 EGFR-IN-206 Inhibitor / Unkown
HY-170968 EGFR-IN-150 Inhibitor / Unkown
HY-161045 T-1-DOCA Inhibitor / Unkown
HY-13524A AG-1478 hydrochloride Inhibitor / Unkown
HY-163663 AZ14133346 Inhibitor / Unkown
HY-E70709 EGFR T790M Recombinant Human Active Protein Kinase / Unkown
HY-150781 EGFR-IN-71 Inhibitor / Unkown
HY-158313 PROTAC EGFR degrader 13 Inhibitor / Unkown
HY-183292 SH-1092 Inhibitor / Unkown
HY-178242 PROTAC EGFR degrader 16 Degrader / Unkown
HY-104080 HG-5-88-01 Inhibitor / Unkown
HY-N1988R Cucurbitacin IIa (Standard) Inhibitor / Unkown
HY-177379 EGFR ligand-14 / Unkown
HY-153856A TAS2940 fumarate Inhibitor / Unkown
HY-146474 EGFR-IN-54 Inhibitor / Unkown
HY-173146 EGFR-IN-153 Inhibitor / Unkown
HY-10368 EGFR/VEGFR2-IN-4 Inhibitor / Unkown
HY-12008S1 Erlotinib-13C6 hydrochloride Inhibitor / Unkown
HY-115933 EGFR/BRAF-IN-1 Inhibitor / Unkown
HY-181056 EGFR/COX-2-IN-3 Inhibitor 99.76% Unkown
HY-114253 ODS-2004436 / Unkown
HY-183120 EGFR T790M/FAK-IN-2 Inhibitor / Unkown
HY-P10569 Biotin HER-2 substrate peptide / Unkown
HY-163657 HER2-IN-20 Inhibitor / Unkown
HY-183310 EGFR-IN-210 Inhibitor / Unkown
HY-157432 EGFR-IN-97 Inhibitor / Unkown
HY-120857 BPIQ-II hydrochloride Inhibitor / Unkown
HY-161146 EGFR-IN-100 Inhibitor / Unkown
HY-165394 Melafolone Inhibitor / Unkown
HY-169982 EGFR-IN-136 Inhibitor / Unkown
HY-176938A iAfaPhos1 / Unkown
HY-172470A DSPE-PEG3400-GE11 / Unkown
HY-172534 BPN-01 Substrate / Unkown
HY-146423 PROTAC EGFR degrader 6 Degrader / Unkown
HY-N6678S (Rac)-Zearalanone-d6 Degrader / Unkown
HY-100064S1 O-Desmethyl gefitinib-d6 Inhibitor / Unkown
HY-162891 EGFR-IN-123 Inhibitor / Unkown
HY-163726 GLUT1/EGFR-IN-1 Inhibitor 99.75% Unkown
HY-151162 HER2-IN-12 Inhibitor / Unkown
HY-180965 Pro-PEG3-BA Degrader / Unkown
HY-181502 EGFR-IN-197 Inhibitor / Unkown
HY-169309 EGFR-IN-133 Inhibitor / Unkown
HY-184719 VEGFR-2-IN-88 Inhibitor / Unkown
HY-180964 Lys-PEG3-BA Degrader / Unkown
HY-112405 BPIQ-I Inhibitor / Unkown
HY-178057 EGFR-IN-176 Inhibitor / Unkown
HY-P2548 pp60 (v-SRC) Autophosphorylation Site, Phosphorylated / Unkown
HY-E70702 EGFR d747-752/P753S Recombinant Human Active Protein Kinase / Unkown
HY-159101 EP26 Inhibitor / Unkown
HY-RS04467 Erbb2 Mouse Pre-designed siRNA Set A Inhibitor / Unkown
HY-101959 Tyrphostin AG213 Inhibitor / Unkown
HY-15772GL Osimertinib (GMP Like) Inhibitor / Unkown
HY-147860 EGFR-IN-61 Inhibitor / Unkown
HY-RS04211 Egfr Rat Pre-designed siRNA Set A Inhibitor / Unkown
HY-181166 EGFR-IN-194 Inhibitor / Unkown
HY-147862 EGFR-IN-62 Inhibitor / Unkown
HY-E70706 EGFR L718Q Recombinant Human Active Protein Kinase / Unkown
HY-142680 EGFR-IN-23 Inhibitor / Unkown
HY-161866 EGFR-IN-118 Inhibitor / Unkown
HY-116138 RG-14467 Inhibitor / Unkown
HY-163419 HER2-IN-18 Inhibitor / Unkown
HY-157912 EGFR-IN-102 Inhibitor / Unkown
HY-168514 SOS1/EGFR-IN-2 Inhibitor / Unkown
HY-178824 EGFR-IN-180 Inhibitor / Unkown
HY-177989 ER121 Inhibitor 98.52% Unkown
HY-161319 EGFR-IN-104 Inhibitor / Unkown
HY-176279 Hsp90-IN-42 Inhibitor / Unkown
HY-164988 TX2-120-1 Degrader / Unkown
HY-142678 EGFR-IN-21 Inhibitor / Unkown
HY-158176 EGFR T790M/L858R-IN-5 Inhibitor / Unkown
HY-E70700 EGFR d746-750/T790M/C797S/L858R Recombinant Human Active Protein Kinase / Unkown
HY-P1828 EGFRvIII peptide (PEPvIII) / Unkown
HY-146228 HSP90-IN-13 Inhibitor / Unkown
HY-149846 SIQ17 Inhibitor / Unkown
HY-179485 EGFR/VEGFR2-IN-10 Inhibitor / Unkown
HY-147826 EGFR-IN-60 Inhibitor / Unkown
HY-E70703 EGFR d752-759 Recombinant Human Active Protein Kinase / Unkown
HY-100636 Gefitinib N-oxide Inhibitor / Unkown
HY-RS04471 Erbb3 Rat Pre-designed siRNA Set A Inhibitor / Unkown
HY-142283CS N-Methyl-dosimertinib-d5 / Unkown
HY-184720 VEGFR-2-IN-89 Inhibitor / Unkown
HY-182264 Masoprocol tetrapivalate Inhibitor / Unkown
HY-175864 EGFR-IN-173 Inhibitor / Unkown
HY-163453 HER2-IN-19 Inhibitor / Unkown
HY-146154 EGFR-IN-58 Inhibitor / Unkown
HY-W409652 CLK1/4-IN-2 Inhibitor / Unkown
HY-143729 EGFR-IN-29 Inhibitor / Unkown
HY-10188 SKS-927 Inhibitor / Unkown
HY-138298B Trastuzumab deruxtecan (DAR2) Inhibitor / Unkown
HY-161602 EGFR/HER2-IN-13 Inhibitor / Unkown
HY-172961 EGFR-IN-162 Inhibitor / Unkown
HY-135216 Antiproliferative agent-54 Inhibitor / Unkown
HY-121828 TX-1123 Inhibitor / Unkown
HY-120412 SKLB188 Inhibitor / Unkown
HY-150905 EGFR ligand-2 Inhibitor / Unkown
HY-183311 EGFR-IN-211 Inhibitor / Unkown
HY-181657 EGFR-IN-200 Inhibitor / Unkown
HY-168627 EGFR-IN-135 Inhibitor / Unkown
HY-149344 Anticancer agent 133 Inhibitor / Unkown
HY-149633 EGFR/HER2/DHFR-IN-3 Inhibitor / Unkown
HY-179150 EGFR-TK-IN-6 Inhibitor / Unkown
HY-172621 EGFR-IN-159 Inhibitor / Unkown
HY-P11590 WGYRGFYC Ligand / Unkown
HY-174414 EGFR/HER2-IN-18 Inhibitor / Unkown
HY-161968 EGFR/PI3Kα-IN-1 Inhibitor / Unkown
HY-13595R Chrysophanol (Standard) Inhibitor / Unkown
HY-151573 EGFR/CDK2-IN-1 Inhibitor / Unkown
HY-P10659 Self-assembling peptide pY1 / Unkown
HY-116277 Z118332870 Inhibitor / Unkown
HY-162602 EGFR-IN-115 Inhibitor / Unkown
HY-155227S ALK/EGFR-IN-1-d5 Inhibitor / Unkown
HY-149556 MTX-241F Inhibitor / Unkown
HY-103566A LY456236 free base Inhibitor / Unkown
HY-185780 Trastuzumab-DM21 Inhibitor / Unkown
HY-146170 Anticancer agent 69 Inhibitor / Unkown
HY-173492 EGFR-IN-156 Inhibitor / Unkown
HY-178005 EGFR-IN-174 Inhibitor / Unkown
HY-176938 AfaPhos1 Inhibitor / Unkown
HY-W777297 Lapatinib-13C2,15N Ditosylate / Unkown
HY-164490 LS-106 Inhibitor / Unkown
HY-172623 EGFR/HER2-IN-17 Inhibitor / Unkown
HY-153557 HER2-IN-13 Inhibitor / Unkown
HY-181061 COX/5-LO-IN-2 Inhibitor / Unkown
HY-145867 EGFR-IN-45 Inhibitor / Unkown
HY-175316 EGFR-IN-168 Inhibitor / Unkown
HY-168469 EGFR-IN-148 Inhibitor / Unkown
HY-181479 EGFR-IN-196 Inhibitor / Unkown
HY-10261S1 Afatinib-d4 Inhibitor / Unkown
HY-144444 NSC381467 Inhibitor / Unkown
HY-151154 EGFR/HER2/DHFR-IN-1 Inhibitor / Unkown
HY-179522 EGFR-IN-186 Inhibitor / Unkown
HY-18213 EGFR-IN-9 Inhibitor 98.84% Unkown
HY-174841 EGFR/HER2-IN-19 Inhibitor / Unkown
HY-169308 EGFR-IN-132 Inhibitor / Unkown
HY-W008914 (E/Z)-CP-724714 Inhibitor / Unkown
HY-157324 EGFR-IN-94 Inhibitor / Unkown
HY-162323 EGFR-IN-106 Inhibitor / Unkown
HY-172156 EGFR-TK-IN-5 Inhibitor / Unkown
HY-173619 EGFR-IN-160 Inhibitor / Unkown
HY-160564 ZNL-0056 Inhibitor / Unkown
HY-18957B Lifirafenib maleate Inhibitor / Unkown
HY-171252 EGFR-IN-145 Inhibitor / Unkown
HY-179049 EGFR/tubulin-IN-1 Inhibitor / Unkown
HY-168876 AZ14240475 Inhibitor / Unkown
HY-162589 Lw13 Inhibitor / Unkown
HY-144097 HER2-IN-8 Inhibitor / Unkown
HY-178283 EGFR-IN-177 Inhibitor / Unkown
HY-138298C Trastuzumab deruxtecan (DAR4) Inhibitor / Unkown
HY-179140 EGFR/VEGFR2-IN-8 Inhibitor / Unkown
HY-179098 Multi-target kinase-IN-8 Inhibitor / Unkown
HY-137028 2′-Thioadenosine Inhibitor / Unkown
HY-161603 EGFR/HER2-IN-14 Inhibitor / Unkown
HY-155074 EGFR-IN-79 Inhibitor / Unkown
HY-174826 EGFR-IN-164 Inhibitor / Unkown
HY-156115 EGFR/CDK2-IN-3 Inhibitor / Unkown
HY-162483 EGFR kinase inhibitor 6 Inhibitor / Unkown
HY-169346 Pred17 Inhibitor / Unkown
HY-143901 EGFR-IN-40 Inhibitor / Unkown
HY-151161 EGFR/HER2-IN-8 Inhibitor / Unkown
HY-175805 EGFR/HDAC-IN-2 Inhibitor / Unkown
HY-161030 EGFR-IN-92 Inhibitor / Unkown
HY-144053 EGFR-IN-36 Inhibitor / Unkown
HY-155227 ALK/EGFR-IN-1 Inhibitor / Unkown
HY-161632 PROTAC EGFR degrader 10 Degrader / Unkown
HY-P5745A TYVPANASL TFA / Unkown
HY-173367 Anticancer agent 271 Inhibitor / Unkown
HY-172897 EGFR/DHFR-IN-2 Inhibitor / Unkown
HY-18298 PD 173955 analog 1 Inhibitor / Unkown
HY-145824 EGFR-IN-43 Inhibitor / Unkown
HY-107450 PROTAC Her3-binding moiety 2 Inhibitor / Unkown
HY-146471 EGFR-IN-51 Inhibitor / Unkown
HY-181093 EGFR-IN-191 Inhibitor / Unkown
HY-142517 EGFR-IN-25 Inhibitor / Unkown
HY-RS04474 Erbb4 Rat Pre-designed siRNA Set A Inhibitor / Unkown
HY-E70704 EGFR G719C Recombinant Human Active Protein Kinase / Unkown
HY-183402 FLLL12 Inhibitor / Unkown
HY-135725 D-69491 hydrochloride Inhibitor / Unkown
HY-50896S3 Erlotinib-d8 Inhibitor / Unkown
HY-180480 NSC 104999 Ligand / Unkown
HY-111072 ADS103317 / Unkown
HY-10325R CL-387785 (Standard) Inhibitor / Unkown
HY-169755 Tyrphostin 63 Inhibitor / Unkown
HY-50898CS Lapatinib-d4 tosylate Inhibitor / Unkown
HY-180325 DDC4002 Inhibitor / Unkown
HY-117252 HS-72 / Unkown
HY-32718S Pelitinib-d6 / Unkown
HY-103443A HKI-357 dimaleate Inhibitor / Unkown
HY-110045 ZM-306416 hydrochloride Inhibitor / Unkown
HY-178740 GI261520A Inhibitor / Unkown
HY-159047 EGFR ligand-10 Degrader / Unkown
HY-116068 DW532 Inhibitor / Unkown
HY-160068 2-2(t) aptamer sodium Chemical 99.28% Unkown
HY-158829 SSOe26 sodium / Unkown
HY-16069S Tucatinib-d6 Inhibitor / Unkown
HY-137081 AKOS024836912 Inhibitor / Unkown
HY-N14635 Paeciloquinone A Inhibitor / Unkown
HY-15495B (3S)-Tanzisertib hydrochloride Inhibitor / Unkown
HY-N14637 Paeciloquinone C Inhibitor / Unkown
HY-169948 BML-265 Inhibitor / Unkown
HY-N14639 Paeciloquinone E Inhibitor / Unkown
HY-183456 Tyrphostin AG17 Inhibitor / Unkown
HY-163396 EGFR-IN-107 Inhibitor / Unkown
HY-183377 DMBT Inhibitor / Unkown
HY-50896S2 Erlotinib-d4 Inhibitor / Unkown
HY-156487 CNBDA Inhibitor / Unkown
HY-158828A SSO111 sodium scrambled negative control / Unkown
HY-184315 LDC8201 Inhibitor / Unkown
HY-169566 EGFR-IN-146 Inhibitor / Unkown
HY-N14638 Paeciloquinone D Inhibitor / Unkown
HY-164527 Si306 Inhibitor / Unkown
HY-N14640 Paeciloquinone F Inhibitor / Unkown
HY-117523 (Z)-RG-13022 Inhibitor / Unkown
HY-50898S4 Lapatinib-d7 Inhibitor / Unkown
HY-N14636 Paeciloquinone B Inhibitor / Unkown
HY-183400 BIM-46174 Inhibitor / Unkown
HY-158829A SSOe26 sodium scrambled negative control / Unkown
HY-153887 HyT36(-Cl) Control / Unkown
HY-135727 PF-6422899 Inhibitor / Unkown
HY-W740378 1,2,3,4-Tetrahydro Staurosporin Inhibitor / Unkown
HY-15769A WHI-P180 hydrochloride Inhibitor / Unkown
HY-180498 NSC 57148 Inhibitor / Unkown
HY-169570 EGFR-IN-149 Inhibitor / Unkown
HY-N20729 Eucommin A Modulator / Unkown
HY-168305 EGFR ligand-11 / Unkown
HY-32721S Neratinib-d6 Inhibitor / Unkown
HY-19909A NRC-2694-A Inhibitor / Unkown
HY-158828 SSO111 sodium / Unkown
HY-114667 Lavendustin C6 Inhibitor / Unkown
HY-146262 LDC0496 Inhibitor / Unkown
Inhibitory Antibodies (65)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P9907A Trastuzumab (anti-HER2) Inhibitor 99.838% Unkown
HY-P9S0008 Cetuximab (PBS) Inhibitor 99.33% Unkown
HY-P99854 Disitamab Inhibitor 98.73% Unkown
HY-P9912A Pertuzumab (anti-HER2) Inhibitor 99.10% Unkown
HY-P990947 Tilatamig Inhibitor 99.99% Unkown
HY-P990957 Ficerafusp alfa 99.71% Unkown
HY-P99866 Duligotuzumab Inhibitor 99.17% Unkown
HY-P99684 Laprituximab Inhibitor 99.74% Unkown
HY-P990238 Anti-Human/Rat HER2 (neu) Antibody (7.16.4) Inhibitor 95.00% Unkown
HY-P991748 Anti-Human/Mouse Amphiregulin Antibody (AR37) Inhibitor 99.544% Unkown
HY-P9977A Amivantamab (FUT8-KO) Inhibitor 98% Unkown
HY-P990755 Pamvatamig 95.298% Unkown
HY-P99892 Serclutamab 99.97% Unkown
HY-P99948 Etevritamab 97.00% Unkown
HY-P99324 Tomuzotuximab Inhibitor ≥99.0% Unkown
HY-P99715 Losatuxizumab Inhibitor 99.44% Unkown
HY-P99618 Fidasimtamab Inhibitor 95.00% Unkown
HY-P99406A Petosemtamab (FUT8-KO) Degrader 99% Unkown
HY-P99558 Timigutuzumab Inhibitor 97.53% Unkown
HY-P991662 AMG-595 Antibody 96.94% Unkown
HY-P990978 Caxmotabart 96.56% Unkown
HY-P990962 Vislarafusp alfa 98.98% Unkown
HY-P99888 Pimurutamab 99.42% Unkown
HY-P990909 Calotatug 98% Unkown
HY-P991780 Anti-Mouse HER2 (domain I) Antibody (H2Mab-304) Inhibitor 97.589% Unkown
HY-P991966 Anti-Human/Mouse EGFR Antibody (7A7) 99.45% Unkown
HY-P990695 Lunaxafusp (His Tag) Inhibitor / Unkown
HY-P992128 Rinumafusp alfa Inhibitor 97.09% Unkown
HY-P992138 Vadalentamig Inhibitor 95.29% Unkown
HY-P991505 Anti-HER3 Antibody (Ab562) Antagonist 99.63% Unkown
HY-P991159 Ruzaltatug Inhibitor 95.69% Unkown
HY-P991779 Anti-Mouse/Human/Canine HER2 (domain III) Antibody (H2Mab-19) Inhibitor 99.05% Unkown
HY-P992107 Dulpatatug Inhibitor 99.09% Unkown
HY-P990972 Azerutamig / Unkown
HY-P992137 Turigrobart Inhibitor 99.9% Unkown
HY-P990698 Umizortamig 96.90% Unkown
HY-P992140 Varzutamig Inhibitor / Unkown
HY-P992130 Rolditamig Inhibitor 95.26% Unkown
HY-P991234 COVA208 Degrader / Unkown
HY-P991985 Anti-Her4 Antibody Inhibitor / Unkown
HY-P990408 Anti-ERBB1/EGFR/HER1 Antibody Inhibitor / Unkown
HY-P990755A Pamvatamig (FUT8-KO) Inhibitor / Unkown
HY-P992171 ADCT-701 Antibody / Unkown
HY-P991969 LR004 Inhibitor / Unkown
HY-P991968 HTI-1511 Antibody Inhibitor / Unkown
HY-P9968A Nimotuzumab (powder) Inhibitor / Unkown
HY-P990049A Becotatug (powder) Inhibitor / Unkown
HY-P991236 MHES0488A Inhibitor / Unkown
HY-P991967 AVID100 Antibody Inhibitor / Unkown
HY-P99295A Imgatuzumab (FUT8-KO) Inhibitor / Unkown
HY-P991986 Anti-Epiregulin Antibody Inhibitor / Unkown
HY-P992401 M802 Inhibitor / Unkown
HY-P991970 REGN3124 Inhibitor / Unkown
HY-P991783 Anti-Mouse EGFR (domain I) Antibody (EMab-300) Inhibitor / Unkown
HY-P991979 Erbicin Inhibitor / Unkown
HY-P991239 NM-02 Inhibitor / Unkown
HY-P991980 H2Mab-139 Inhibitor / Unkown
HY-P991245 Anti-ERBB3/HER3 (SGP1) Inhibitor / Unkown
HY-P991977 BSI-001 Inhibitor / Unkown
HY-P991092A IBI-334 (FUT8-KO) Inhibitor / Unkown
HY-P990248 Anti-Mouse E-Cadherin/CD324 Antibody (DECMA-1) Inhibitor / Unkown
HY-P991241 Anti-ERBB3/HER3 (29Z6) Inhibitor / Unkown
HY-P991243 MP-RM-1 Inhibitor 96.29% Unkown
HY-P991573 Anti-EGFR Antibody (D2C7) Inhibitor / Unkown
HY-P991784 Anti-Mouse/Human EGFR (domain III) Antibody (EMab-88) Inhibitor / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Egfr NCBI NCBI:1956